Table 3. Cost of adjuvant chemotherapy by components for societal and payer perspective.
| Mean cost (standard deviation) [EUR] | |||
|---|---|---|---|
| N | Payer perspective | Societal perspective | |
| Administration chemotherapy | 106 | 1,549.81 (385.79) | 1,549.81 (385.79) |
| Chemotherapy drug | 106 | 302.69 (85.35) | 302.69 (85.35) |
| Prophylactic prescription | 106 | 2,440.39 (2249.97) | 2,440.39 (2249.97) |
| Side effect management | 106 | 687.64 (2192.31) | 687.64 (2192.31) |
| Monitoring | 106 | 616.62 (147.33) | 616.62 (147.33) |
| Transport | 106 | 624.84 (512.32) | 714.46 (608.48) |
| Absenteeism | 106 | 1,996.37 (1724.38) | 3,993.39 (3449.32) |
| Total (including absenteeism) | 106 | 8,218.37 (3784.40) | 10,305.01 (4,979.21) |
| Total (without absenteeism) | 106 | 6,222.00 (3181.09) | 6,311.62 (3,215.39) |
All costs are expressed in 2013 Euros (EUR).